Avalo Therapeutics, Inc. · NASDAQ:AVTX

Ra Capital Management, L.P. reported a 9.90% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Ra Capital Management, L.P. reported a 9.90% stake in Avalo Therapeutics, Inc., 1,939,065 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
9.90%
Shares
1,939,065
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
RA Capital Management, L.P.9.90%1,939,065
Peter Kolchinsky9.90%1,939,065
Rajeev Shah9.90%1,939,065
RA Capital Healthcare Fund, L.P.9.90%1,939,065

Source

View original at SEC

Related